Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01819207
Other study ID # 1492MF
Secondary ID
Status Completed
Phase N/A
First received March 24, 2013
Last updated May 31, 2016
Start date April 2013
Est. completion date April 2015

Study information

Verified date March 2013
Source Western Galilee Hospital-Nahariya
Contact n/a
Is FDA regulated No
Health authority Israel: Ethics CommissionIsrael: Ministry of Health
Study type Interventional

Clinical Trial Summary

thromboelastography can identify alteration in the coagulation profile in bariatric patients who undergo sleeve gastrectomy or gastric bypass


Recruitment information / eligibility

Status Completed
Enrollment 93
Est. completion date April 2015
Est. primary completion date April 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patients undergoing bariatric surgery

Exclusion Criteria:

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms

  • Bariatric Patients Undergoing Bariatric Surgery

Intervention

Other:
blood test by thromboelastography


Locations

Country Name City State
Israel Naharia Medical Center Naharia

Sponsors (1)

Lead Sponsor Collaborator
Western Galilee Hospital-Nahariya

Country where clinical trial is conducted

Israel, 

References & Publications (1)

Munro TG. Glass is detectable on plain radiographs. CMAJ. 1989 Feb 15;140(4):365. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary coagulation profile by thromboelastography 1 year No